Please check your internet connection and try again.
# Pantoprazole
## Overview
Pantoprazole is a proton pump inhibitor (PPI) that reduces gastric acid production. It is available in oral and intravenous formulations.
## Primary Indications
* Gastroesophageal reflux disease (GERD)
* Healing of erosive esophagitis
* Pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome)
* Part of *Helicobacter pylori* eradication regimens
## Adult Dosing
* **GERD and Erosive Esophagitis:** 40 mg orally once daily for up to 8 weeks.
* **Maintenance of Healing:** 20 mg to 40 mg orally once daily.
* **Pathological Hypersecretory Conditions:** 40 mg orally or intravenously twice daily, may be increased to 80 mg intravenously or orally twice daily based on response. Doses above 80 mg daily should be divided.
* **IV for IV access complications:** 40 mg intravenously once daily.
* **H. pylori Eradication:** Typically 40 mg orally twice daily in combination with antibiotics.
## Pediatric Dosing
* **Erosive Esophagitis (12 years and older):** 40 mg orally once daily for up to 8 weeks.
* Dosing for younger pediatric patients is not well-established and should be based on institutional protocols and specialist guidance.
## Dose Adjustments
No dose adjustment is generally required for renal impairment. Use with caution in severe hepatic impairment; a reduced dose (e.g., 20 mg daily) may be considered.
## Contraindications
Hypersensitivity to pantoprazole, benzimidazole derivatives, or any component of the formulation.
## Adverse Effects
Common adverse effects include headache, diarrhea, nausea, abdominal pain, and dizziness. Long-term PPI use is associated with an increased risk of *Clostridium difficile*-associated diarrhea, bone fractures, hypomagnesemia, vitamin B12 deficiency, and acute interstitial nephritis.
## Key Drug Interactions
* **CYP2C19 Inhibitors/Inducers:** May affect metabolism of drugs like clopidogrel, warfarin, and methotrexate.
* **Drugs Dependent on Gastric pH:** Absorption of drugs like ketoconazole, itraconazole, and certain antiretrovirals may be reduced.
* **Methotrexate:** Pantoprazole may increase methotrexate levels; consider monitoring.
## Monitoring
* Electrolytes (especially magnesium) with prolonged therapy.
* Renal function, particularly with long-term use or in patients with pre-existing renal disease.
* Vitamin B12 levels with prolonged therapy.
## Clinical Pearls
* Administer oral pantoprazole at least 30 minutes before a meal.
* IV infusion is typically over 15 minutes. Reconstitution and dilution instructions must be followed carefully.
* Consider the lowest effective dose for the shortest duration necessary to manage the condition.
***
This information is intended for healthcare professionals. Always consult the official prescribing information and relevant guidelines for complete details and to verify current recommendations.
